PETROS PHARMACEUTICALS INC's ticker is PTPI and the CUSIP is 71678J100. A total of 24 filers reported holding PETROS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,000 | -37.5% | 10,000 | 0.0% | 0.01% | -37.5% |
Q2 2022 | $8,000 | -50.0% | 10,000 | 0.0% | 0.01% | -46.7% |
Q1 2022 | $16,000 | -51.5% | 10,000 | 0.0% | 0.02% | -48.3% |
Q4 2021 | $33,000 | -41.1% | 10,000 | -64.3% | 0.03% | -40.8% |
Q3 2021 | $56,000 | -36.4% | 28,000 | 0.0% | 0.05% | -36.4% |
Q2 2021 | $88,000 | – | 28,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
One68 Global Capital, LLC | 24,883 | $109,000 | 0.22% |
CM Management, LLC | 45,000 | $198,000 | 0.18% |
NorthRock Partners, LLC | 385,031 | $1,694,000 | 0.17% |
ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 62,700 | $276,000 | 0.11% |
Platform Technology Partners | 44,000 | $194,000 | 0.10% |
Shay Capital LLC | 45,940 | $202,000 | 0.04% |
NEVILLE RODIE & SHAW INC | 21,875 | $96,000 | 0.01% |
Cannell & Co. | 25,484 | $112,000 | 0.00% |
Renaissance Technologies | 143,247 | $630,000 | 0.00% |
BREWIN DOLPHIN LTD | 2,143 | $9,429 | 0.00% |